The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2 study of STP938, a first-in-class inhibitor of CTP synthase 1, in patients with relapsed/refractory B or T cell lymphoma.
 
Manish R. Patel
Leadership - ION Pharma
Honoraria - Janssen Oncology
Consulting or Advisory Role - Olema Pharmaceuticals
Research Funding - Accutar Biotech (Inst); Accutar Biotech (Inst); Acerta Pharma (Inst); Adagene (Inst); ADC Therapeutics (Inst); Agenus (Inst); Aileron Therapeutics (Inst); Artios (Inst); Artios (Inst); Artios (Inst); Artios (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bicycle Therapeutics (Inst); BioNTech (Inst); BioTheryX (Inst); BioTheryX (Inst); Black Diamond Therapeutics (Inst); Black Diamond Therapeutics (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); CicloMed (Inst); Clovis Oncology (Inst); Compugen (Inst); Compugen (Inst); Cullinan Oncology (Inst); cyteir (Inst); Daiichi Sankyo (Inst); Erasca, Inc (Inst); Evelo Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); H3 Biomedicine (Inst); Hengrui Therapeutics (Inst); Hutchison MediPharma (Inst); IgM Biosciences (Inst); IgM Biosciences (Inst); Immune-Onc Therapeutics (Inst); Immunitas (Inst); Immunogen (Inst); Jacobio (Inst); Janssen (Inst); Jazz Pharmaceuticals (Inst); Klus Pharma (Inst); Kymab (Inst); Lilly (Inst); Loxo (Inst); LSK BioPharma (Inst); Lycera (Inst); MabSpace Biosciences (Inst); MabSpace Biosciences (Inst); Macrogenics (Inst); Merck (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Moderna Therapeutics (Inst); NGM Biopharmaceuticals (Inst); NGM Biopharmaceuticals (Inst); NGM Biopharmaceuticals (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); nurix (Inst); Nurix (Inst); Olema Oncology (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Pionyr (Inst); Prelude Therapeutics (Inst); PureTech (Inst); PureTech (Inst); Puretech (Inst); Relay Therapeutics (Inst); Relay Therapeutics (Inst); Revolution Medicines (Inst); Ribon Therapeutics (Inst); Ribon Therapeutics (Inst); Samumed (Inst); Seven and Eight Biopharmaceuticals (Inst); Silicon Therapeutics (Inst); Step Pharma (Inst); Syndax (Inst); Syndax (Inst); Synthorx (Inst); Taiho Pharmaceutical (Inst); TeneoBio (Inst); Tesaro (Inst); TopAlliance BioSciences Inc (Inst); Treadwell Therapeutics (Inst); Treadwell Therapeutics (Inst); Treadwell Therapeutics (Inst); Vigeo Therapeutics (Inst); Xencor (Inst); Zymeworks (Inst)
 
Matthew Ahearne
Research Funding - Step Pharma
Travel, Accommodations, Expenses - Medscape
 
Kim Linton
Leadership - Epcoritamab Global Council
Consulting or Advisory Role - Abbvie; BeiGene; Bristol-Myers Squibb; Celgene; Genmab; Kite/Gilead; Roche
Speakers' Bureau - Abbvie; Celgene
Research Funding - Abbvie; ADC Therapeutics; AstraZeneca; BeiGene; Bristol-Myers Squibb; Celgene; CellCentric; Genmab; Janssen; Kite/Gilead; MorphoSys; MSD; Nurix; Regeneron; Roche; Step Pharma; Viracta Therapeutics
Travel, Accommodations, Expenses - Celgene
 
Christopher Fox
Consulting or Advisory Role - Abbvie; AstraZeneca; Atara Biotherapeutics; BeiGene; Bristol-Myers Squibb/Celgene; Genmab; Gilead Sciences; Lilly; MorphoSys/Incyte; Ono Pharmaceutical; Roche; Takeda
Speakers' Bureau - Abbvie; Bristol-Myers Squibb/Celgene; Gilead Sciences; Incyte; Janssen; Roche; Takeda
Research Funding - BeiGene
Travel, Accommodations, Expenses - Roche
 
David John Lewis
Consulting or Advisory Role - BeiGene; Janssen Oncology; Kite/Gilead
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Maureen Higgins
Employment - Step Pharma
Stock and Other Ownership Interests - Step Pharma
 
Brian E. Schwartz
Employment - Step Pharma
Leadership - Cyclacel; Enlivex Therapeutics Ltd; Infinity Pharmaceuticals
Stock and Other Ownership Interests - Cyclacel; Enlivex Therapeutics Ltd; Infinity Pharmaceuticals; Step Pharma
 
Philip A Beer
Employment - Step Pharma
Stock and Other Ownership Interests - Step Pharma
 
Michael Timothy Tees
No Relationships to Disclose